K.J. Harrison & Partners Inc Sells 9,000 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

K.J. Harrison & Partners Inc lessened its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 31.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,000 shares of the company's stock after selling 9,000 shares during the quarter. K.J. Harrison & Partners Inc's holdings in Henry Schein were worth $1,370,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. Investment Management Corp VA ADV bought a new position in shares of Henry Schein during the fourth quarter valued at $32,000. Rakuten Securities Inc. acquired a new stake in Henry Schein in the first quarter valued at $34,000. Smartleaf Asset Management LLC raised its position in Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after purchasing an additional 143 shares during the last quarter. UMB Bank n.a. raised its position in Henry Schein by 23.2% during the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares during the last quarter. Finally, Menard Financial Group LLC acquired a new position in Henry Schein during the 4th quarter worth about $92,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Stock Up 2.0%

NASDAQ:HSIC traded up $1.43 during trading hours on Tuesday, reaching $74.48. The company had a trading volume of 1,598,947 shares, compared to its average volume of 1,719,796. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50. The firm has a market cap of $9.07 billion, a price-to-earnings ratio of 23.28, a P/E/G ratio of 2.36 and a beta of 0.87. The business's 50-day simple moving average is $70.16 and its two-hundred day simple moving average is $71.15.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same period last year, the business posted $1.10 EPS. The firm's revenue for the quarter was down .1% compared to the same quarter last year. On average, equities analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analyst Weigh In

HSIC has been the subject of several recent research reports. Barrington Research decreased their price target on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research note on Tuesday, May 6th. Piper Sandler lowered their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a report on Wednesday, April 30th. Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Finally, Wells Fargo & Company decreased their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Henry Schein currently has an average rating of "Moderate Buy" and an average price target of $79.30.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.